Cell Works Therapeutics

Cellworks is a precision medicine company that utilizes computational biology to predict individual patient responses to oncology treatments. The company's proprietary Computational Biology Model (CBM) creates a "digital twin" of a patient's unique disease state, allowing for the simulation of drug effects and the identification of optimal therapy combinations. This approach aims to eliminate the trial-and-error nature of cancer treatment by providing clinicians with data-driven insights into drug efficacy and resistance. Their flagship products, Singula and Ventura, are designed to assist in the treatment of hematological malignancies and solid tumors, respectively. Beyond clinical decision support, Cellworks partners with pharmaceutical companies to streamline drug development and enhance clinical trial success rates.